We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.01B
AUM Growth
+$275M
Cap. Flow
+$223M
Cap. Flow %
22.14%
Top 10 Hldgs %
24.16%
Holding
3,706
New
246
Increased
2,543
Reduced
445
Closed
132

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$11.6M
2
NVDA icon
NVIDIA
NVDA
+$8.23M
3
MSFT icon
Microsoft
MSFT
+$7.53M
4
AMZN icon
Amazon
AMZN
+$3.51M
5
META icon
Meta Platforms (Facebook)
META
+$3.34M

Sector Composition

Rank Sector Weight
1 Technology 24.3%
2 Financials 11.78%
3 Healthcare 9.71%
4 Industrials 7.92%
5 Consumer Discretionary 7.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUMA icon
2851
Humacyte
HUMA
$194M
$1.25K ﹤0.01%
229
+71
+45% +$468
VSEC icon
2852
VSE Corp
VSEC
$6.12B
$1.24K ﹤0.01%
15
+6
+67% +$522
CCCC icon
2853
C4 Therapeutics
CCCC
$412M
$1.24K ﹤0.01%
+217
New +$1.31K
MTW icon
2854
Manitowoc
MTW
$675M
$1.23K ﹤0.01%
128
+76
+146% +$792
SPT icon
2855
Sprout Social
SPT
$621M
$1.22K ﹤0.01%
42
+20
+91% +$651
TITN icon
2856
Titan Machinery
TITN
$445M
$1.21K ﹤0.01%
87
+10
+13% +$150
AEM icon
2857
Agnico Eagle Mines
AEM
$90.5B
$1.21K ﹤0.01%
15
CLFD icon
2858
Clearfield
CLFD
$374M
$1.21K ﹤0.01%
31
+4
+15% +$156
SCPH
2859
DELISTED
scPharmaceuticals
SCPH
$1.21K ﹤0.01%
265
+164
+162% +$793
GPCR icon
2860
Structure Therapeutics
GPCR
$3.78B
$1.19K ﹤0.01%
27
+11
+69% +$425
TARS icon
2861
Tarsus Pharmaceuticals
TARS
$2.84B
$1.18K ﹤0.01%
36
-104
-74% -$2.92K
METC icon
2862
Ramaco Resources Class A
METC
$649M
$1.18K ﹤0.01%
104
+102
+5,100% +$1.22K
WVE icon
2863
Wave Life Sciences
WVE
$1.2B
$1.18K ﹤0.01%
144
+110
+324% +$658
BY icon
2864
Byline Bancorp
BY
$1.76B
$1.18K ﹤0.01%
44
+6
+16% +$159
ANGL icon
2865
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.11B
$1.18K ﹤0.01%
+40
New +$1.16K
CIM
2866
Chimera Investment
CIM
$1B
$1.17K ﹤0.01%
74
+62
+517% +$928
TPB icon
2867
Turning Point Brands
TPB
$1.74B
$1.17K ﹤0.01%
27
+25
+1,250% +$955
AVD icon
2868
American Vanguard Corp
AVD
$68.9M
$1.16K ﹤0.01%
+219
New +$1.55K
CBU icon
2869
Community Bank
CBU
$3.41B
$1.16K ﹤0.01%
+20
New +$1.15K
CVRX icon
2870
CVRx
CVRX
$63.4M
$1.15K ﹤0.01%
+131
New +$1.19K
ONEW icon
2871
OneWater Marine
ONEW
$201M
$1.15K ﹤0.01%
48
-164
-77% -$4.03K
INDI icon
2872
indie Semiconductor
INDI
$854M
$1.15K ﹤0.01%
287
-3,843
-93% -$18.7K
PLRX icon
2873
Pliant Therapeutics
PLRX
$65M
$1.14K ﹤0.01%
102
+23
+29% +$288
IGMS
2874
DELISTED
IGM Biosciences
IGMS
$1.14K ﹤0.01%
+69
New +$756
SKYT
2875
DELISTED
SkyWater Technology
SKYT
$1.14K ﹤0.01%
+125
New +$1.04K

Similar funds

GAMMA Investing's Q3 2024 Portfolio in Review

As of Q3 2024, GAMMA Investing held 3,706 positions worth $1.01B, up 37% from $734M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

GAMMA Investing deployed $223M of net new capital in Q3 2024, opening 246 new positions and adding to 2,543 existing holdings. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 28,428 shares worth $2.61M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Chevron, an estimated $216K trimmed.

  • GAMMA Investing's largest Q3 2024 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 28,428 shares worth $2.61M.
  • GAMMA Investing added most to Apple in Q3 2024, an estimated $11.6M increase.
  • GAMMA Investing's biggest Q3 2024 reduction was Chevron, cutting an estimated $216K.
  • GAMMA Investing fully exited iShares iBonds 2025 Term High Yield and Income ETF in Q3 2024, selling an estimated $1.21M.
  • GAMMA Investing's ten largest holdings make up 24% of its $1.01B portfolio in Q3 2024.
  • GAMMA Investing opened 246 new positions and closed 132 in Q3 2024.
  • GAMMA Investing's portfolio value rose 37% quarter-over-quarter to $1.01B.

Based on GAMMA Investing's 13F filing for Q3 2024, filed 7 Oct 2024.